Final answer:
The nurse will suggest discussing topical immunosuppressants with the healthcare provider.
Step-by-step explanation:
The nurse will suggest discussing topical immunosuppressants with the healthcare provider.
When a child with eczema has been treated unsuccessfully with a topical glucocorticoid for a long period of time and has developed skin atrophy and hypopigmentation, it indicates that the child is not responding well to the glucocorticoid treatment. In such cases, topical immunosuppressants may be a more appropriate option. These medications, such as tacrolimus and pimecrolimus, work by suppressing the immune response in the skin, reducing inflammation and itching.
Topical immunosuppressants are considered second-line treatments for eczema, typically used when other treatment options have been ineffective or when glucocorticoids are not recommended due to side effects. They can be an effective alternative to glucocorticoids in managing eczema and preventing adverse effects.